Statement attributable to:
Patrice A. Harris, MD, MA
President-elect, chair of the AMA Opioid Task Force
American Medical Association
“The AMA applauds the FDA and Commissioner Gottlieb for today’s action to provide labeling that would allow for over-the-counter availability of naloxone, a move that will save people from opioid-related overdose. Naloxone has saved tens of thousands of lives, and the AMA continues to strongly urge physicians to co-prescribe naloxone to patients at risk of opioid-related overdose.
“As called for by AMA policy and ongoing advocacy, today’s action should spur efforts by naloxone manufacturers to submit applications for their products to receive over-the-counter status. Doing so would be an important step to save even more lives from a national epidemic.”
ph: (202) 789-7442
About the American Medical Association
The American Medical Association is the premier national organization providing timely, essential resources to empower physicians, residents and medical students to succeed at every phase of their medical lives. Physicians have entrusted the AMA to advance the art and science of medicine and the betterment of public health on behalf of patients for more than 170 years.